2nd German arab CanCer ConGress29th – 30th October 2015
in Berlin
sessions and Workshops
Deutsch-Arabischer Krebskongress
www.dakk-berlin.de
Charité Comprehensive Cancer Center
Shaping Future healthCancer Diagnostics and Treatment
multidimensional – interdisciplinary – interprofessional
2
We would like to thank the sponsors and supporters of the 2nd German arab Cancer Congress:
҉ W.o.m. WorLD oF meDICIne GmbH
҉ TonTarra medizintchnik GmbH
҉ baxalta Deutschland GmbH
҉ amgen GmbH
҉ roche Pharma aG
҉ astraZeneca GmbH
҉ Federal ministry of Health
Updated: 21 October 2015. Mistakes and printing errors as well as changes in the program are subject to change without notice.
3
opening Ceremony: 29 october 2015, 09:30 – 10:30
Dr. eric schweitzerPresident of the Berlin Chamber of Commerce and Industry and President of the Association of German Chambers of Commerce and Industry (DIHK)
michael müllerGoverning Mayor of Berlin
H.e. Prof. Dr. med. ossama bin abdul majed shobokshiDoyen of the Council of Arab Ambassadors in Germany and Ambassador of the Kingdom of Saudi Arabia
Dr. otto WiesheuPresident of the German-Arab Friendship Association (DAFG)
H.e. ambassador Dr. badr eddin al-alali [tbc!]Assistant Secretary General of the League of Arab States
ortwin schulte Federal Ministry of Health
official opening of the 2nd German arab Cancer Congress
Prof. Dr. med. Ulrich KeilholzActing Director of the Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin
Prof. Dr. med. abdulgabar salamaHead of the Immuno-Hematology Clinic, Institute for Transfusion Medicine, Charité - Universitätsmedizin Berlin
Prof. Dr. med. Jalid sehouliHead of the Department of Gynecology, Campus Virchow and Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin
4
session 1: Plenary session
molecular Disease Characteristics – Is There arab european Diversity?
29.10.2015 10:45 – 12:30 h
Chair: Prof. Ulrich Keilholz (Germany) / Prof. Shaheen Al-Ahwal (Saudi Arabia)
10:45 – 11:00 molecular Profiling of Cancer: Where We stand in egypt? prof. Wafaa h. el Metnawy, MD,phD (Cairo university, egypt)
11:00 – 11:15 molecular and Functional Profiling of Colorectal Cancer – Charité Programs pD Dr. Markus Morkel (Charité - universitäts- medizin Berlin, germany)
11:15 – 11:30 molecular Features of Colorectal Cancer among egyptian Patients prof. nadia Mokhtar (nCi – Cairo university, egypt)
11: 30 – 11:45 molecular oncology - Defining Targetable mutations in Cancer Dr. Konrad Klinghammer (Charité - universitäts- medizin Berlin, germany)
11:45 – 12:00 Panel sequencing: Turning experimental Profiling into routine Pathology pD Dr. Frederick Klauschen (Charité - universitäts- medizin Berlin, germany)
12:00 – 12:30 Panel Discussion – all participants
5
session 2: management of breast Cancer
29.10.2015 13:30 – 15:00 h
Chair: Prof. Jens-Uwe Blohmer (Germany) / Prof. Omar Z. Youssef M.D (Egypt)
13:30 – 13:45 are Developing Countries ready for Intraoperative radiotherapy Treatment for breast Cancer? prof. Maha S a abdel hadi (university of Dammam, Saudi-arabia)
13:45 - 14:00 Changing Paradigms in radiation oncology prof. Volker Budach (Charité - universitätsmedizin Berlin, germany)
14:00 - 14:15 Therapeutic mammoplasty a Third Path for surgical management breast Cancer prof. Omar Z. Youssef M.D (nCi – Cairo university, egypt)
14:15 - 14:30 Charité: surgery news prof. Jens-uwe Blohmer (Charité - universitäts- medizin Berlin, germany)
14:30 – 14:45 Therapy of Ductal Carcinoma in situ Dr. Fakher ismaeel (Charité - universitätsmedizin Berlin, germany)
14:45 – 15:00 Discussion
6
session 3: surgical management of Colorectal Cancer
29.10.2015 15:00 – 16:30 h
Chair: Prof. Martin E. Kreis (Germany) / PD Dr. Markus Morkel (Germany) / Prof. Wael Gawad M.D., Ph.D., FRCS (Egypt)
15:00 – 15:15 management of Patients with Colon Cancer prof. Martin Kreis (Charité - universitätsmedizin Berlin, germany)
15:15 – 15:30 robotic Low anterior resection in rectal Cancer - Preliminary results NCI Experience prof. ashraf S. Zaghloul M.D (nCi – Cairo university, egypt)
15:30 – 15:45 Transanaler Zugang zur tiefen rektumresektion – TamIs Tme Dr. Felix aigner (Charité - universitätsmedizin Berlin, germany)
15:45 – 16:00 extended Pelvic resection in the surgical management of recurrent rectal Cancer prof. Wael gawad M.D., ph.D., FrCS (nCi – Cairo university, egypt)
16:00 – 16:15 Pushing the limits - surgery for liver metastasis prof. Johann pratschke (Charité - universitäts- medizin Berlin, germany)
16:15 – 16:30 Discussion
7
session 4: management of Head and neck Cancer
29.10.2015 16:30 – 17:45 h
Chair: Prof. Ulrich Keilholz (Germany) / Prof. Volker Budach (Germany) / Prof. Ashraf S. Zaghloul M.D (Egypt)
16:30 – 16:45 Challenges of Head and neck Cancer: egyptian Perspectives prof. ayman a. amin (nCi – Cairo university, egypt)
16:45 – 17:00 novel Trials in Head and neck Cancer Dr. Carmen Stromberger (Charité - universitäts- medizin Berlin, germany)
17:00 – 17:15 Clinical Implications of molecular Head-and- neck-cancer subgroups prof. ulrich Keilholz (Charité - universitätsmedizin Berlin, germany)
17:15 – 17:30 a retrospective study of Clinico-epidemiological aspects of nasopharyngeal Cancer at nCI - Cairo ass. prof. azza taher (Cairo university, egypt)
17:30 – 17:45 Discussion
8
session 5: management of Lung Cancer
30.10. 2015 8:30 – 09:45 h
Chair: Dr. Matthias Paland / Prof. Hatem Abo Elkassem (Egypt)
08:30 – 08:45 a Clinico-epidemiological study of Cases of Locally advanced Lung Cancer (nsCLC) Following radiotherapy. ass. prof. azza taher (Cairo university, egypt)
08:45 – 09:05 Treatment approach to oligometastatic Disease Dr. Moritz hilbrandt / pD Dr. pirus ghadjar (both Charité - universitätsmedizin Berlin, germany)
09:05 – 09:20 eGFr & aLK Profile in Lung Cancer prof. nadia Mokhtar (nCi – Cairo university, egypt)
09:20 – 09:35 new agents in Lung Cancer Dr. Sebastian Ochsenreither (Charité - universitäts- medizin Berlin, germany)
09:35 – 09:45 Discussion
9
session 6: management of ovarian Cancer and other Gynecological malignancies
30.10.2015 09:45 – 11:45 h
Chairs: Prof. Jalid Sehouli / Dr. Jan Dieckmann / Prof. Gamal Emira (Egypt)
9:45 – 10:00 Gynaecologic oncology in egypt; Current situation and Future Direction ahmed Morsi (nCi – Cairo university, egypt)
10:00 – 10:15 Genetic aspect of ovarian Cancer prof. Wafaa h. el Metnawy, MD, phD (Cairo university, egypt)10:15 – 10:30 Current aspect of multimodal Therapy of advanced ovarian Cancer in Germany and europe prof. Jalid Sehouli (Charité - universitätsmedizin Berlin, germany)10:30 – 10:45 Pattern & management of recurrent ovarian Cancer prof. gamal emira (nCi – Cairo university, egypt)10:45 – 10:55 Current aspects of surgery in Cervical Cancer Dr. M. Zellal Muallem (Charité - universitäts- medizin Berlin, germany)10:55 – 11:05 state of the art, Gynecological sarcomas Dr. Khalid el Khalfaoui (germany)11:05 – 11:15 The surgical staging of endometrial Cancer. state of the art Dr. ahmed el-Balat (universitätsklinikum Frankfurt, germany)11:15 – 11:25 new aspects of Vulvar Cancer Therapy pD Dr. uwe torsten (Vivantes Klinikum neukölln, germany)11:25 – 11:45 Discussion
10
session 7: Counseling aspects with emphasis on Cultural Diversity
30.10.2015 12:45 – 14:00 h
Chair: Dipl.-Psych. Anna Stickel / Prof. Nadia Mokhtar (Egypt)
12:45 – 13:00 Genetic Testing and management of Hereditary breast Cancer prof. Wafaa h. el Metnawy, MD,phD (Cairo university, egypt)
13:00 – 13:15 Psycho-educational Programs and Coping mechanisms of Families of Patients with Cancer prof. Samir abo al Magd (Cairo university, egypt)
13:15 – 13:30 Posttraumatic Care – a German-arab Comparison pD Dr. Stefan röpke (Charité - universitätsmedizin Berlin, germany)
13:30 – 13:45 Working Group migration Program Baharan naghavi (Charité - universitätsmedizin Berlin, germany)
13:45 - 14:00 Discussion
11
session 8: Pediatric oncology
30.10.2015 14:00 – 15:15 h
Chair: Prof. Angelika Eggert (Germany) / Prof. Hany Hussein (Egypt)
14:00 – 14:15 overwiew of Paediatric oncology in egypt prof. hany hussein (Cairo university, egypt)
14:15 – 14:30 neuroblastoma prof. Johannes Schulte (Charité - universitäts- medizin Berlin, germany)
14:30 – 14:45 Pediatric Hodgkin’s Disease, Children Cancer Hospital -75375- experience prof. hany hussein (nCi – Cairo university, egypt)
14:45 – 15:00 molecular Genetic alterations in Pediatric acute Lymphoblastic Leukemia and their relevance for Treatment stratification Dr. renate Kirschner-Schwabe (Charité - univer- sitätsmedizin Berlin, germany)
15:00 - 15:15 Discussion
12
session 9: open session for Free Presentations
30.10.2015 15:15 – 17:30 h
Chair: Prof. Jalid Sehouli (Germany) / Prof. Wael S. Abd El-Gawad (Egypt) / Prof. Mohamed Lotayef (Egypt - Dean of NCI)
15:15 – 15:30 HPV-screening for Cervical cancer in europe and Worldwide pD Dr. andreas Kaufmann (Charité - universitäts- medizin Berlin, germany)
15:30 – 15:45 aftercare in africa – How to reach Cancer Patients? thomas von Kalckstein (World health identification, Berlin, germany)
15:45 – 16:00 experiences of WHo Initiatives in morocco pD Dr. axel-peter Schäfer (Charité - universitäts- medizin Berlin, germany)
16:00 – 16:15 Treatment of bleeding related to Platelets in malignant and non-malignant Diseases prof. abdulgabar Salama (Charité - universitäts- medizin Berlin, germany)
16:15 – 16:30 Value added of PeT/CT in Patients with metasteses of Unknown Primary ass. prof. azza taher (Cairo university, egypt)
16:30 – 16:45 options and Limits of early Detection in Gynecological malignancies Dr. alia Soliman (aachen, germany)
13
16:45 – 17:00 Poor Compliance to Tyrosine Kinase Inhibitors Lowers Cytogenetic response and overall survival in Patients with Chronic myeloid Leukemia
prof. Salam alkindi (Sultan Qaboos university, Oman)
17:00 – 17:15 Cytotoxicity of 35 medicinal Plants from sudan towards sensitive and multidrug-resistant Cancer Cells Mohamed Saeed (institute of pharmacy and Biochemistry, Johannes gutenberg-university Mainz, germany)
17:15 – 17:30 Discussion
14
Poster session
30.10.2015 17:30 h
Chair: Prof. Ahmed Morsi M.D (Egypt) / Prof. Maha Abdel Hadi (KSA) / Prof. Ulrich Keilholz (Germany) / Prof. Jalid Sehouli (Germany)
sphincter-saving and abdomino-perineal resections Following neoadjuvant Chemoradiation in Locally advanced Low rectal Cancerprof. hatem abo elkassem (egypt)
subsequent malignancies among Long-term survivors of Hodgkin Lymphoma and non-Hodgkin Lymphoma: a Pooled analysis of German Cancer registry Data (1990-2011). nadia Baras (Charité - universitätsmedizin Berlin, germany)
activity of the Dietary Flavonoid, apigenin, against multidrug-resistant Tumor Cells as Determined by Pharmacogenomics and molecular DockingMohamed Saeed(1), Onat Kadioglu(1), hassan Khalid(2), Yoshikazu Sugimoto(3), thomas efferth(1)*1. Department of Pharmaceutical Biology, Institute of Pharmacy and
Biochemistry, Johannes Gutenberg University, Mainz, Germany. 2. The Medicinal and Aromatic Plants Research Institute (MAPRI), National
Centre for Research, Khartoum, Sudan3. Division of Chemotherapy, Faculty of Pharmacy, Keio University, Tokyo,
Japan
15
The Lignan, (−)-sesamin reveals Cytotoxicity toward Cancer Cells: Pharmacogenomic Determination of Genes associated with sensitivity or resistance Mohamed Saeed(a), hassan Khalid(b), Yoshikazu Sugimoto(c), thomas efferth(a)*a. Department of Pharmaceutical Biology, Institute of Pharmacy and
Biochemistry, Johannes Gutenberg University, Mainz, Germanyb. Medicinal and Aromatic Plants Research Institute (MAPRI), National Centre
for Research, Khartoum, Sudanc. Division of Chemotherapy, Faculty of Pharmacy, Keio University, Tokyo,
Japan
Linking Tumor evolution and Therapy response Using Diagnostic-targeted next-generation sequencing in Colorectal CancerDr. Soulafa Mamlouk
eXPressIon V – First Interim results of a study regarding Preferences and expectations of breast and ovarian Cancer Patients D. Dimitrova, naghavi, u. Keilholz, J. SehouliCharité Comprehensive Cancer Center, Department of gynecology
Die Anerkennung als ärztliche Fortbildungsmaßnahme und Bewertung mit Fortbildungspunkten durch die Ärztekammer Berlin (ÄKB) ist beantragt.Fortbildungspunkte können nach der erforderlichen Eintragung in der Teilnahmeliste zum 1. Deutsch-Arabischen Krebskongress beantragt werden.
Berlin Medical Association (ÄKB) is requested to certify this conference as part of continuous medical education with CME credit points. You can apply for CME credit points after registration in the list of participants of 1st German Arab Medical Conference in Berlin 2014.
